Table 3 The number of ELISPOT spots of IFN-γ on splenic lymphocytes of mice in each of the three groups
From: Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
Group | HPV16 | HPV18 | HPV58 |
|---|---|---|---|
AD-HPV16/18/58 mE6E7 vaccine group | 168.33 ± 8.963* | 204.67 ± 11.676* | 234.00 ± 29.614* |
AD-NC group | 8.00 ± 4.359 | 9.33 ± 1.528 | 8.67 ± 4.041 |
PBS group | 7.67 ± 2.517 | 6.33 ± 2.062 | 8.67 ± 2.517 |